Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Exemplar Pharma, LLC

Latest From Exemplar Pharma, LLC

Allergan Manufacturing Headaches Continue For Semprana

Inhalable acute migraine drug previously known as Levadex receives third “complete response” letter from FDA.

BioPharmaceutical Manufacturing

Allergan Manufacturing Headaches Continue For Semprana

Inhalable acute migraine drug previously known as Levadex receives third “complete response” letter from FDA.

BioPharmaceutical Clinical Trials

Earnings Briefs: Sanofi, Amgen, Aegerion, Vertex, MorphoSys, Allergan

Launches go well for Vertex’s Kalydeco and Aegerion’s Juxtapid, but for Sanofi, the pipeline hits keep on coming.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Allergan, Inc.
UsernamePublicRestriction

Register